Literature DB >> 8021512

Activation of protein kinase C down-regulates leukotriene C4 synthase activity and attenuates cysteinyl leukotriene production in an eosinophilic substrain of HL-60 cells.

A Ali1, A W Ford-Hutchinson, D W Nicholson.   

Abstract

An eosinophilic substrain of HL-60 cells (HL-60#7) predominantly synthesized cysteinyl leukotrienes after stimulation with the calcium ionophore A23187. Activation of protein kinase C (PKC) by phorbol 12-myristate 13-acetate (PMA) specifically attenuated cysteinyl leukotriene production without affecting the biosynthesis of non-cysteinyl leukotrienes. The inhibition of cysteinyl leukotriene biosynthesis was prevented only by specific PKC inhibitors (staurosporine and bisindolylmaleimide) but not by inhibitors of tyrosine kinases (genistein, tyrphostin 47, and herbimycin A), protein kinase A (KT5720), or the oxidative burst (apocynin). Similar results were obtained when LTC4 synthase enzymatic activity was measured directly in the presence of saturating concentrations of exogenously added substrates. Therefore, the inhibitory effects of PKC activation on cysteinyl leukotriene formation in intact cells was attributable to effects on the LTC4 synthase enzyme. The mechanism of inhibition of LTC4 synthase by PKC activation was determined by kinetic analysis to be noncompetitive in both eosinophil-like HL-60#7 cells and monocytic THP-1 cells. Contrary to the effect of PKC activation on cysteinyl leukotriene biosynthesis, the formation of prostaglandin E2 and thromboxane B2 was elevated twofold to threefold after PMA treatment, which was prevented by the PKC inhibitor, staurosporine. We propose a regulatory model in which PKC activation shifts the profile of eicosanoid mediators produced by eosinophils from cysteinyl leukotrienes to prostanoids.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8021512

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  13 in total

Review 1.  Regulation of expression of the 5-lipoxygenase pathway.

Authors:  T D Bigby
Journal:  Clin Rev Allergy Immunol       Date:  1999 Spring-Summer       Impact factor: 8.667

Review 2.  The organization and consequences of eicosanoid signaling.

Authors:  Roy J Soberman; Peter Christmas
Journal:  J Clin Invest       Date:  2003-04       Impact factor: 14.808

3.  Molecular cloning of the human leukotriene C4 synthase gene and assignment to chromosome 5q35.

Authors:  T D Bigby; C R Hodulik; K C Arden; L Fu
Journal:  Mol Med       Date:  1996-09       Impact factor: 6.354

4.  Protein kinase C activation inhibits eosinophil degranulation through stimulation of intracellular cAMP production.

Authors:  Charles I Ezeamuzie; Najla Taslim
Journal:  Br J Pharmacol       Date:  2004-10-25       Impact factor: 8.739

5.  Eicosanoid mediator expression in mononuclear and polymorphonuclear cells in normal subjects and patients with atopic asthma and cystic fibrosis.

Authors:  L M Kuitert; R Newton; N C Barnes; I M Adcock; P J Barnes
Journal:  Thorax       Date:  1996-12       Impact factor: 9.139

6.  Allelic association and functional studies of promoter polymorphism in the leukotriene C4 synthase gene (LTC4S) in asthma.

Authors:  I Sayers; S Barton; S Rorke; B Beghé; B Hayward; P Van Eerdewegh; T Keith; J B Clough; S Ye; J W Holloway; A P Sampson; S T Holgate
Journal:  Thorax       Date:  2003-05       Impact factor: 9.139

7.  Phosphorylation of Leukotriene C4 Synthase at Serine 36 Impairs Catalytic Activity.

Authors:  Shabbir Ahmad; A Jimmy Ytterberg; Madhuranayaki Thulasingam; Fredrik Tholander; Tomas Bergman; Roman Zubarev; Anders Wetterholm; Agnes Rinaldo-Matthis; Jesper Z Haeggström
Journal:  J Biol Chem       Date:  2016-06-30       Impact factor: 5.157

8.  A mechanism of benefit of soy genistein in asthma: inhibition of eosinophil p38-dependent leukotriene synthesis.

Authors:  R Kalhan; L J Smith; M C Nlend; A Nair; J L Hixon; P H S Sporn
Journal:  Clin Exp Allergy       Date:  2007-11-02       Impact factor: 5.018

Review 9.  Leukotriene biosynthetic enzymes as therapeutic targets.

Authors:  Jesper Z Haeggström
Journal:  J Clin Invest       Date:  2018-07-02       Impact factor: 14.808

10.  Negative regulation of Fc epsilon RI-mediated degranulation by CD81.

Authors:  T J Fleming; E Donnadieu; C H Song; F V Laethem; S J Galli; J P Kinet
Journal:  J Exp Med       Date:  1997-10-20       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.